Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis
Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis
저자
Kim, Jin Seok; Suh, Cheolwon; Cheong, June-Won; Kim, Kihyun; Kim, Yang Soo; Lee, Se-Ryeon; Bae, Sung Hwa; Joo, Young-Don; Lee, Sang Min; Eom, Hyeon Seok; Park, Eunkyung; Yoon, Sung-Soo; Kim, Inho; Kwak, Jae-Yong; Min, Chang-Ki; Kim, Jeong-A; Park, Moo-Rim; Kim, Sung Hyun; Kang, Hye Jin; Kim, Min Kyoung; Kim, Hawk; Mun, Yeung-Chul; Kim, Hoon-Gu; Lee, Moon Hee; Lee, Jae Hoon